Table 2.

Characteristics of the included studies.

StudyIndex StudiedDisease Severity ComparatorClaims-based VariablesAdjusted Measure of Association
Correlation to RARBIS with Medication SubscaleCorrelation to RARBIS without Medication Subscale
Ting, 200824CIRASRARBISAge and sex0.080.05
Rheumatology visits0.01
Rehabilitation visits0.010.04
Felty’s syndrome0.010.03
No. inflammatory markers ordered0.140.08
Rheumatoid factor test ordered0.020.04
No. platelet counts ordered0.030.01
No. chemistry panels ordered0.010.02
Composite CIRAS score0.56 (p < 0.0001)0.51 (p < 0.0001)
Wolfe, 200630Composite score for RA severity indexPASAgeAUC = 0.64AUC = 0.70
SexFor detection of PAS above or below median value for cohortFor detection of 1st vs 4th PAS quartile for cohort
Disease duration
Current DMARD and/or biologics
Lifetime number of DMARD and/or biologics
  • AUC: Area under the curve; CIRAS: claims-based index for RA severity; PAS: Patient Activity Score; RARBIS: RA medical records-based index of severity; RA: rheumatoid arthritis; DMARD: disease-modifying antirheumatic drug.